The largest database of trusted experimental protocols

B27 insulin

Manufactured by Bio-Techne

B27-insulin is a supplement for cell culture media that contains a defined mixture of nutrients, hormones, and other components. It is designed to support the growth and differentiation of a variety of cell types, including neuronal and stem cells. The core function of B27-insulin is to provide a standardized, serum-free supplement to promote cell survival and proliferation in cell culture applications.

Automatically generated - may contain errors

2 protocols using b27 insulin

1

Cardiomyocyte Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to differentiation, cells were dissociated with Accutase™ (StemCell Technologies, Vancouver, BC, Canada) and passaged to six-well plates. Until 100% confluence of iPSCs, NutriStem™ (Biological Industries) was refreshed. On day 0, the medium was changed to 3 mL of RPMI (Biological Industries), supplemented with 0.5% L-glutamine (Biological Industries), B27-Insulin (Invitrogen, Carlsbad, CA, USA) and 4.5 µM CHIR-99021 (Tocris, Bristol, UK). On day 2, the medium was changed to 3 mL of RPMI supplemented with 0.5% L-glutamine, B27-Insulin, and 5 µM IWP-2 (Tocris). On day 4, the medium was changed to 3 mL of RPMI supplemented with 0.5% L-glutamine and B27-Insulin. This medium was refreshed on day 6. On day 8, the medium was changed to 3 mL of RPMI supplemented with 0.5% L-glutamine and B27, and this medium was refreshed on day 10. From day 12, the medium was changed to M-199 (Biological Industries), supplemented with 0.1% penicillin/streptomycin, 5% fetal bovine serum (FBS, Biological Industries), 0.6 mM CuSO4·5 H2O, 0.5 mM ZnSO4·7 H2O, and 1.5 mM Vitamin B12 (Sigma-Aldrich, Darmstadt, Germany). This medium was refreshed every other day.
+ Open protocol
+ Expand
2

Cardiac Differentiation of Induced Pluripotent Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to differentiation,
cells were passed to 6-well plates. NutriStem was refreshed daily
until iPSCs reached 100% confluence. At that point (Day 0), the medium
was changed to 3 mL of RPMI (Biological Industries), supplemented
with 0.5% l-glutamine (Biological Industries), B27-Insulin
(Invitrogen, Carlsbad, California), and 4.5 μM CHIR-99021 (Tocris,
Bristol, UK). On Day 2, the medium was changed to 3 mL of RPMI supplemented
with 0.5% l-glutamine, B27-Insulin, and 5 μM IWP-2
(Tocris). On Day 4, the medium was changed to 3 mL of RPMI supplemented
with 0.5% l-glutamine and B27-Insulin, and this medium was
refreshed on Day 6. On Days 8 and 10, the medium was changed to 3
mL of RPMI supplemented with 0.5% l-glutamine and B27. From
Day 12, the medium was changed to M-199 (Biological Industries), supplemented
with 0.1% penicillin/streptomycin, 5% fetal bovine serum (FBS, Biological
Industries), 0.6 mM CuSO4·5H2O, 0.5 mM
ZnSO4·7H2O, and 1.5 mM Vitamin B12 (Sigma-Aldrich).
This medium was refreshed every other day.74 (link)
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!